Table 3. Comparison of antimicrobial susceptibility patterns for Staphylococcus aureus isolates from case-players, carriers, and players X and Y*.
| Antimicrobial drug | Case-players (2003) | Nasal carriage strains (2003) |
Player X |
Player Y |
||||
|---|---|---|---|---|---|---|---|---|
| A† | B | C | Wound (2002) | Nasal (2003) | Wound (2002) | Wound (2003) | ||
| Penicillin | R | R | R | R | R | R | R | R |
| Oxacillin | R | R | R | R | R | R | R | R |
| Gentamicin | S | S | NT | S | S | NT | S | S |
| Levofloxacin | I | I | S | R | I | I | I | I |
| Vancomycin | S | S | S | S | S | S | S | S |
| Clindamycin | S | S | S | R | S | S | S | S |
| Tetracycline | S | S | S | S | S | NT | S | S |
| Rifampin | S | S | S | S | S | NT | S | S |
| Trimethoprim-sulfamethoxazole | NT | NT | S | S | NT | S | NT | NT |
*R, resistant; S, susceptible; I, Intermediate; NT, susceptibility was not tested for that particular antimicrobial drug. †Strain A is indistinguishable on pulsed-field gel electrophoresis from a community-associated MRSA strain (USA300).